Monopoly v. Openness: Two Sides of IP Coin in the Pharmaceutical Industry

Forthcoming, Journal of World Intellectual Property

16 Pages Posted: 24 Jun 2017 Last revised: 1 May 2019

See all articles by Olga Gurgula

Olga Gurgula

Brunel University London - Brunel Law School; University of Oxford - Oxford Martin School

Date Written: June 23, 2017

Abstract

The pharmaceutical industry extensively relies on the patent system. It actively lobbies for the strengthening of the patent protection of its medical products. The results of its efforts may be found in bilateral and multilateral agreements, including the TRIPS and the most recent TPPA, and in private patent strategies pursued by pharmaceutical companies. However, some recent developments reflect the emerging tendency of pharmaceutical companies to implement different business models — models that may mark the beginning of transformation of this industry. Among these developments is an ‘open innovation’ model, increasingly followed by research institutions and pharmaceutical companies, that aims to facilitate the creation of new and affordable medicines, and provide transparency in order to enhance safety and efficacy of drugs. This article will discuss these two opposing forces in the pharmaceutical industry: strong IP protection and open innovation.

Keywords: patents; the pharmaceutical industry; access to medicines; open innovation

Suggested Citation

Gurgula, Olga, Monopoly v. Openness: Two Sides of IP Coin in the Pharmaceutical Industry (June 23, 2017). Forthcoming, Journal of World Intellectual Property, Available at SSRN: https://ssrn.com/abstract=2991642

Olga Gurgula (Contact Author)

Brunel University London - Brunel Law School ( email )

Kingston Lane
Elliott Jaques Building
Uxbridge, Middlesex UB8 3PH
United Kingdom

University of Oxford - Oxford Martin School ( email )

University of Oxford
34 Broad Street
Oxford, OX1 3BD
United Kingdom

Here is the Coronavirus
related research on SSRN

Paper statistics

Downloads
112
Abstract Views
435
rank
272,709
PlumX Metrics